The incidence of pulmonary embolism (PE) is high during severe Coronavirus Disease 2019
(COVID-19). We aimed to identify predictive and prognostic factors of PE in non-ICU …

Objective To determine the incidence, characteristics, and risk factors of pulmonary
embolism (PE) among patients hospitalized for COVID-19. Patients and Methods We …

Introduction The incidence, characteristics, and prognosis of pulmonary embolism (PE) in
Coronavirus disease 2019 (COVID-19) have been poorly investigated. We aimed to …

Background Pulmonary embolism (PE) has been described in coronavirus disease 2019
(COVID-19) critically ill patients, but the evidence from more heterogeneous cohorts is …

Background A high prevalence of pulmonary embolism (PE) has been described during
COVID‐19. Our aim was to identify predictive factors of PE in non‐ICU hospitalized COVID …

Abstract Background Coronavirus disease 2019 (COVID-19) is characterised by dyspnoea
and abnormal coagulation parameters, including raised D-dimer. Data suggests a high …

Recent studies suggest that thrombotic complications are a common phenomenon in the
novel SARS-CoV-2 infection. The main objective of our study is to assess cumulative …

Objectives Emerging results indicate that, in COVID-19, thromboembolic complications
contribute to the high mortality and morbidity. Previous research showed that the prevalence …

Background Coronavirus disease 2019 (COVID-19) may predispose to venous
thromboembolism. We determined factors independently associated with computed …

Introduction Coronavirus disease 2019 (COVID-19) pneumonia is associated to systemic
hyper-inflammation and abnormal coagulation profile. D-dimer elevation is particularly …